These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Psycho-immunological mechanisms in schizophrenia]. Karanikas EP Psychiatriki; 2011; 22(1):43-52. PubMed ID: 21688524 [TBL] [Abstract][Full Text] [Related]
28. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Müller N; Hofschuster E; Ackenheil M; Eckstein R Acta Psychiatr Scand; 1993 Jan; 87(1):66-71. PubMed ID: 8093825 [TBL] [Abstract][Full Text] [Related]
29. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541 [TBL] [Abstract][Full Text] [Related]
30. Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder. O'Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd A; Wakefield D; McConaghy N Psychiatry Res; 1996 Dec; 65(3):171-8. PubMed ID: 9029665 [TBL] [Abstract][Full Text] [Related]
31. [Modern approaches to the study of immunity in schizophrenia]. Koliaskina GI; Burbaeva GSh Vestn Akad Med Nauk SSSR; 1979; (7):76-84. PubMed ID: 395791 [No Abstract] [Full Text] [Related]
32. The behavior of T lymphocytes in schizophrenia. Liedeman RR; Prilipko LL Birth Defects Orig Artic Ser; 1978; 14(5):365-77. PubMed ID: 308380 [No Abstract] [Full Text] [Related]
33. Glutamine as an activator of immune cells: how does it work? Cynober L Nutrition; 1997; 13(7-8):688-9. PubMed ID: 9556357 [No Abstract] [Full Text] [Related]
34. The role of immune function in schizophrenia: an overview. Müller N; Riedel M; Ackenheil M; Schwarz MJ Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():62-8. PubMed ID: 10654111 [TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against 60-kDa heat shock protein in schizophrenia. Schwarz MJ; Riedel M; Gruber R; Müller N; Ackenheil M Eur Arch Psychiatry Clin Neurosci; 1998; 248(6):282-8. PubMed ID: 9928906 [TBL] [Abstract][Full Text] [Related]
36. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics. Monteleone P; Valente B; Maj M; Kemali D Biol Psychiatry; 1991 Jul; 30(2):201-4. PubMed ID: 1680471 [No Abstract] [Full Text] [Related]
37. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Müller N; Ackenheil M; Hofschuster E; Mempel W; Eckstein R Psychiatry Res; 1991 May; 37(2):147-60. PubMed ID: 1678892 [TBL] [Abstract][Full Text] [Related]
38. [A change of immune profile of patients with schizophrenia during treatment]. Koliaskina GI; Sekirina TP; Androsova LV; Kushner SG; Vasil'eva EF; Burbaeva OA; Morozova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):39-45. PubMed ID: 15270298 [TBL] [Abstract][Full Text] [Related]
39. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia. Yang ZW; Chengappa KN; Shurin G; Brar JS; Rabin BS; Gubbi AV; Ganguli R Psychol Med; 1994 May; 24(2):449-55. PubMed ID: 8084939 [TBL] [Abstract][Full Text] [Related]
40. Cytokine production in unmedicated and treated schizophrenic patients. Rothermundt M; Arolt V; Leadbeater J; Peters M; Rudolf S; Kirchner H Neuroreport; 2000 Oct; 11(15):3385-8. PubMed ID: 11059907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]